Next Article in Journal
In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments
Next Article in Special Issue
The Role of Blood Microbiome in the Development of Thyroid Cancer in Breast Cancer Survivors
Previous Article in Journal
Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review
Previous Article in Special Issue
Differential Impact of Exercises on Quality-of-Life Improvement in Breast Cancer Survivors: A Network Meta-Analysis of Randomized Controlled Trials
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

The Breaking Point and Post-Traumatic Growth in Breast Cancer Survivors

Breast Unit, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, 00168 Roma, Italy
*
Author to whom correspondence should be addressed.
Cancers 2023, 15(18), 4441; https://doi.org/10.3390/cancers15184441
Submission received: 28 July 2023 / Revised: 1 September 2023 / Accepted: 4 September 2023 / Published: 6 September 2023
(This article belongs to the Special Issue Breast Cancer Survivors and Supportive Therapies)
Advancements in breast cancer survival rates make the issues of quality of life and psycho-physical wellbeing in survivors central goals of comprehensive care.
Anticancer treatments, along with outstanding results on prognosis [1], also carry burdensome toxicities for every aspect (physical, emotional, social, or financial) of a woman’s life, as well as side effects and sequelae, even in the long term [2,3].
Unfortunately, the long-lasting consequences of a cancer journey on body image and weight [4,5], physical function [6], sexual health [7,8], psychological balance [9,10], and spiritual issues are hugely underdiagnosed and these patients’ needs are rarely met.
The health questions that remain unanswered during the survivorship trajectory hamper complete recovery after cancer experience and, in some cases, represent a threat to the survivor’s chances of cure. In particular, the increased rates of being overweight and sedentary habits in breast cancer survivors have been shown to negatively affect not only their quality of life, but also their disease-free survival, secondary cancers, and cardiovascular disease rates [11,12,13].
Despite this, supportive therapies and lifestyle remodulation programs are almost never proposed as a standard of care post-diagnosis, and the quality of life of cancer survivors has long been neglected in daily practice and clinical trials, until recent times [14].
The present Special Issue focuses on these topics, trying to shed light on some of the evidence-based resources in the field.
Furthermore, there is still an insufficient and patchy use of patient-reported outcome (PRO) measures and the patient’s perspective is seldom considered in defining the primary outcomes in clinical studies, with a consequent underestimation of the toxicities and goals that matter to cancer patients [15,16].
When diagnosed with cancer, every woman has to face a breaking point, from which there will be a life “before” and “after” that moment. Along the cancer journey, underrating the negative impact that lifesaving anticancer treatments will unavoidably have on her body–mind balance, self-efficacy, and overall wellbeing will reduce the patient’s compliance to treatments and could, in some cases, convince her to abandon evidence-based therapies for unproven and dangerous alternative proposals.
An integrative holistic approach to every breast cancer patient, since diagnosis, should include an assessment of her lifestyles (nutrition, physical activity, sleep), psychological resources, and needs in order to improve her coping, enhance adherence to the treatment protocols, and reduce their side effects, even through non-pharmacological treatments [17,18].
This approach must be safe, rational, and evidence-based, tailored to the patient’s needs and preferences, according to the healthcare professional experience, and possibly provided in the same center where the oncological treatments are given.
In the first phases, prehabilitation to the active treatments, such as surgery and chemotherapy, may be needed; even small modifications in dietary and physical activity habits, smoking and alcohol cessation or reduction, relaxation strategies, sleep hygiene, and medical optimization just before or during these therapies could reduce perioperative complications and improve physical and psycho-social outcomes [19]. In the long term, the best chances for rehabilitation and supportive care must be provided in order to prevent and alleviate symptoms and sequelae along the pathway of care.
By helping the patient to remodulate her habits, when needed, during and beyond the cancer trajectory, she feels involved in a more proactive follow up, which becomes not only a period of surveillance for disease relapses, but also a window of opportunity for oncologists, psycho-oncologists, and other professionals to prescribe, motivate, and monitor positive behavioral changes in a comprehensive risk-reducing strategy.
By using arts for therapeutic purposes, such as music, dance, writing, and figurative arts, under the supervision of trained professionals, the individual experience of cancer can be told, manipulated, and transformed into something that could help to find a sense to one’s suffering.
Eventually, by recognizing and sustaining individual resources, an integrative model could help survivors to find a new balance for the rest of their lives (no matter how long) and enhance their post-traumatic growth beyond the disease [20].

Author Contributions

A.F.: Conceptualization, Investigation, Writing—Original Draft, Writing—Review and Editing. S.M.: Conceptualization, Methodology, Writing—Review and Editing. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Taylor, C.; McGale, P.; Probert, J.; Broggio, J.; Charman, J.; Darby, S.C.; Kerr, A.J.; Whelan, T.; Cutter, D.J.; Mannu, G.; et al. Breast cancer mortality in 500,000 women with early invasive breast cancer in England, 1993–2015: Population based observational cohort study. BMJ 2023, 381, e074684. [Google Scholar] [CrossRef] [PubMed]
  2. Runowicz, C.D.; Leach, C.R.; Henry, N.L.; Henry, K.S.; Mackey, H.T.; Cowens-Alvarado, R.L.; Cannady, R.S.; Pratt-Chapman, M.L.; Edge, S.B.; Jacobs, L.A.; et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA A Cancer J. Clin. 2016, 66, 43–73. [Google Scholar]
  3. Offodile, A.C.; Asaad, M.; Boukovalas, S.; Bailey, C.; Lin, Y.L.; Teshome, M.; Greenup, R.A.; Butler, C. Financial Toxicity Following Surgical Treatment for Breast Cancer: A Cross-sectional Pilot Study. Ann. Surg. Oncol. 2021, 28, 2451–2462. [Google Scholar] [CrossRef] [PubMed]
  4. Zhao, W.; Chong, Y.Y.; Chien, W.T. Effectiveness of cognitive-based interventions for improving body image of patients having breast cancer: A systematic review and meta-analysis. Asia-Pacific J. Oncol. Nurs. 2023, 10, 100213. [Google Scholar] [CrossRef] [PubMed]
  5. Campbell, N.J.; Barton, C.; Cutress, R.I.; Copson, E.R. Impact of obesity, lifestyle factors and health interventions on breast cancer survivors. Proc. Nutr. Soc. 2023, 82, 47–57. [Google Scholar] [CrossRef] [PubMed]
  6. Harrington, S.; Padua, D.; Battaglini, C.; Michener, L.A.; Giuliani, C.; Myers, J.; Groff, D. Comparison of shoulder flexibility, strength, and function between breast cancer survivors and healthy participants. J. Cancer Surviv. 2011, 5, 167–174. [Google Scholar] [CrossRef] [PubMed]
  7. Sousa Rodrigues Guedes, T.; Barbosa Otoni Gonçalves Guedes, M.; de Castro Santana, R.; Costa da Silva, J.F.; Almeida Gomes Dantas, A.; Ochandorena-Acha, M.; Terradas-Monllor, M.; Jerez-Roig, J.; Bezerra de Souza, D.L. Sexual Dysfunction in Women with Cancer: A Systematic Review of Longitudinal Studies. Int. J. Environ. Res. Public Health 2022, 19, 11921. [Google Scholar] [CrossRef] [PubMed]
  8. Hernández-Blanquisett, A.; Quintero-Carreño, V.; Álvarez-Londoño, A.; Martínez-Ávila, M.C.; Diaz-Cáceres, R. Sexual dysfunction as a challenge in treated breast cancer: In-depth analysis and risk assessment to improve individual outcomes. Front. Oncol. 2022, 12, 955057. [Google Scholar] [CrossRef] [PubMed]
  9. Fernandes-Taylor, S.; Adesoye, T.; Bloom, J.R. Managing psychosocial issues faced by young women with breast cancer at the time of diagnosis and during active treatment. Curr. Opin. Support. Palliat. Care 2015, 9, 279–284. [Google Scholar] [CrossRef] [PubMed]
  10. Howell, D.M.; Metcalfe, K.; Kong, S.; Stephen, J.; Olivotto, I.A.; Baxter, N.; Friedenreich, C.M.; Warner, E.; Akbari, M.R.; McBain, K.; et al. Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: A national multicentre cohort study. Breast Cancer Res. Treat. 2022, 194, 91–102. [Google Scholar] [CrossRef] [PubMed]
  11. Willems, R.A.; Winckers, K.; Biesmans, C.; de Vos-Geelen, J.; Cate, H.T. Evolving data on cardiovascular complications in cancer. Thromb. Res. 2022, 213 (Suppl. S1), S87–S94. [Google Scholar] [CrossRef] [PubMed]
  12. A Cannioto, R.; Hutson, A.; Dighe, S.; McCann, W.; E McCann, S.; Zirpoli, G.R.; Barlow, W.; Kelly, K.M.; A DeNysschen, C.; Hershman, D.L.; et al. Physical Activity before, during, and after Chemotherapy for High-Risk Breast Cancer: Relationships with Survival. J. Natl. Cancer Inst. 2021, 113, 54–63. [Google Scholar] [CrossRef] [PubMed]
  13. Miyamoto, T.; Nagao, A.; Okumura, N.; Hosaka, M. Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: A Systematic Review and Meta-analysis. Curr. Oncol. Rep. 2022, 24, 1645–1659. [Google Scholar] [CrossRef] [PubMed]
  14. Cannioto, R.A.; Attwood, K.M.; Davis, E.W.; Mendicino, L.A.; Hutson, A.; Zirpoli, G.R.; Tang, L.; Nair, N.M.; Barlow, W.; Hershman, D.L.; et al. Adherence to Cancer Prevention Lifestyle Recommendations before, during, and 2 Years after Treatment for High-risk Breast Cancer. JAMA Netw. Open 2023, 6, e2311673. [Google Scholar] [CrossRef] [PubMed]
  15. Di Maio, M.; Gallo, C.; Leighl, N.B.; Piccirillo, M.C.; Daniele, G.; Nuzzo, F.; Gridelli, C.; Gebbia, V.; Ciardiello, F.; De Placido, S.; et al. Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015, 33, 910–915. [Google Scholar] [CrossRef] [PubMed]
  16. Marandino, L.; La Salvia, A.; Sonetto, C.; De Luca, E.; Pignataro, D.; Zichi, C.; Di Stefano, R.; Ghisoni, E.; Lombardi, P.; Mariniello, A.; et al. Deficiencies in health-related quality-of-life assessment and reporting: A systematic review of oncology randomized phase III trials published between 2012 and 2016. Ann. Oncol. 2018, 29, 2288–2295. [Google Scholar] [CrossRef] [PubMed]
  17. Rossi, C.; Maggiore, C.; Rossi, M.M.; Filippone, A.; Guarino, D.; Di Micco, A.; Forcina, L.; Magno, S. A Model of an Integrative Approach to Breast Cancer Patients. Integr. Cancer Ther. 2021, 20, 15347354211040826. [Google Scholar] [CrossRef] [PubMed]
  18. Lyman, G.H.; Greenlee, H.; Bohlke, K.; Bao, T.; DeMichele, A.M.; Deng, G.E.; Fouladbakhsh, J.M.; Gil, B.; Hershman, D.L.; Mansfield, S.; et al. Integrative Therapies during and after Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J. Clin. Oncol. 2018, 36, 2647–2655. [Google Scholar] [CrossRef] [PubMed]
  19. Toohey, K.; Hunter, M.; McKinnon, K.; Casey, T.; Turner, M.; Taylor, S.; Paterson, C. A systematic review of multimodal prehabilitation in breast cancer. Breast Cancer Res. Treat. 2023, 197, 1–37. [Google Scholar] [CrossRef] [PubMed]
  20. Capaldi, J.M.; Shabanian, J.; Finster, L.B.; Asher, A.; Wertheimer, J.C.; Zebrack, B.J.; Shirazipour, C.H. Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: A systematic scoping review of interventions. Health Psychol. Rev. 2023, 12, 1–34. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Franco, A.; Magno, S. The Breaking Point and Post-Traumatic Growth in Breast Cancer Survivors. Cancers 2023, 15, 4441. https://doi.org/10.3390/cancers15184441

AMA Style

Franco A, Magno S. The Breaking Point and Post-Traumatic Growth in Breast Cancer Survivors. Cancers. 2023; 15(18):4441. https://doi.org/10.3390/cancers15184441

Chicago/Turabian Style

Franco, Antonio, and Stefano Magno. 2023. "The Breaking Point and Post-Traumatic Growth in Breast Cancer Survivors" Cancers 15, no. 18: 4441. https://doi.org/10.3390/cancers15184441

APA Style

Franco, A., & Magno, S. (2023). The Breaking Point and Post-Traumatic Growth in Breast Cancer Survivors. Cancers, 15(18), 4441. https://doi.org/10.3390/cancers15184441

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop